Latest Strategic Shift News

Knosys’ Greenorbit subsidiary has inked a two-year agency deal with UK-based Oak Engage to offer its advanced intranet platform to existing Greenorbit customers, marking a strategic shift in Knosys’ product focus.

Global Health Limited reports a robust 23% increase in customer receipts and an 85% jump in quarterly operating cashflow, as it advances its transition to AI-enabled SaaS platforms targeting profitability by June 2026.

Truscott Mining has secured a drilling contract to kick off a 2,500-metre RC drilling program at its Westminster Project, alongside appointing a seasoned project geology manager to steer development efforts.

Bass Oil reported steady December production with a notable gas sales agreement for the Vanessa field, signaling a strategic shift towards gas commercialization.

Australian Ethical reported a slight 1% decline in funds under management to $14.08 billion for December 2025, balancing positive retail flows against institutional mandate losses and market headwinds.

Wia Gold has appointed mining veteran Henk Diederichs as Managing Director and CEO, signaling a strategic shift as the Kokoseb Gold Project in Namibia moves toward a Definitive Feasibility Study.

Power Minerals has terminated its joint venture with Navigate Energy on the Rincon Lithium Project, opting to retain full ownership and seek new partners amid a buoyant lithium market.

Proteomics International Laboratories has appointed David Morris as CEO and Managing Director, marking a strategic shift towards commercialising its Promarker® diagnostic technology. Morris brings extensive global healthcare leadership experience to lead the company’s next growth phase.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.

The Lottery Corporation will release its half year financial results for the period ending 31 December 2025 on 18 February 2026, alongside key dates for its interim dividend.

Apiam Animal Health has secured Foreign Investment Review Board approval for its acquisition by Adamantem Capital, paving the way for a crucial shareholder vote in February.

VHM Limited has terminated its offtake agreement with Shenghe Resources to pursue broader global partnerships for its Goschen Rare Earths and Mineral Sands Project, appointing Macquarie Capital to accelerate funding and offtake discussions ahead of production in 2027.